
1 
These Regulations may be cited as the Human Medicines (Amendment) Regulations 2017 and shall come into force on 1st October 2017.
2 
The Human Medicines Regulations 2012 are amended as follows.
3 

(1) Regulation 8 is amended as follows.
(2) In paragraph (1)—
(a) in the appropriate place insert—“
 “external use” in relation to a medicinal product—
(a) means its use by application to the skin, teeth, mucosa of the mouth, throat, nose, ear, eye, vagina or anal canal in circumstances where local action only is necessary and systemic absorption is unlikely to occur; but
(b) does not include its use by means of a throat spray, nasal spray, nasal inhalation or teething preparation or by means of throat pastilles, throat lozenges, throat tablets or nasal drops;”; and
(b) in the definition of “the relevant register”, in paragraph (d)—
(i) after “a physiotherapist” insert “, an orthoptist”;
(ii) in sub-paragraph (ii) omit “or”; and
(iii) after sub-paragraph (iii) insert—“, or
(iv) orthoptists;”.
4 
In regulation 45B, in paragraph (1), after “unless paragraphs” insert “(2)”.
5 

(1) Regulation 167 is amended as follows.
(2) In paragraph (7)—
(a) in sub-paragraph (b), at the end, for the full stop substitute a comma; and
(b) after sub-paragraph (b) insert (as full out words)—“and it is imported by the holder of a wholesale dealer’s licence in relation to the product in question.”.
6 
In regulation 213, in paragraph (1), omit the definition of “external use”.
7 
In regulation 346, in paragraph (2)(d)(iva), after “Part 2 items 4a, 11 and 12,” insert “Part 3 item 11,”.
8 

(1) Schedule 17 is amended as follows.
(2) In the table in Part 1 (exemption from restrictions on sale and supply of prescription only medicines)—
(a) in item 12—
(i) for the words in column 2 substitute—“Prescription only medicines comprising:
(a) an inhaler containing salbutamol; or
(b) an auto-injector containing adrenaline”; and
(ii) in column 3, after “for the purpose of supplying” insert “or administering”; and
(b) in item 13, in column 1, after “Registered orthoptists” insert “against whose names are recorded in the relevant register annotations signifying that they are qualified to sell or supply the medicine specified in column 2”.
(3) In the table in Part 3 (exemptions from the restriction on administration of prescription only medicines), after item 10 in the table insert—“
11 A person (“P”) carrying on the business of a school who is trained to administer the relevant medicine. 11 A prescription only medicine comprising an auto-injector containing adrenaline. 11 The administration shall be—(a) in the course of P carrying on the business of a school;(b) where administration is to a pupil at that school who is known to be at risk of anaphylaxis; and(c) where the pupil requires the medicinal product in an emergency.”
(4) In the table in part 4 (exemption for certain persons who sell or supply certain medicinal products), in item 13, in column 1, after “Registered orthoptists” insert “against whose names are recorded in the relevant register annotations signifying that they are qualified to sell or supply the medicine specified in column 2”.
Signed by the authority of the Secretary of State.
Jackie Doyle-Price
Parliamentary Under Secretary of State,
Department of Health
29th June 2017
Richard Pengelly
A senior official of the Department of Health in Northern Ireland
29th June 2017